Search

Follow

icometrix

icometrix

A partner application on Blackford Platform, icobrain provides an FDA-cleared and CE-marked solution for easy and reliable access to MRI biomarkers that indicate subclinical disease activity in multiple sclerosis, dementia and traumatic brain injury. This allows accelerated diagnosis, aids in facilitating the treatment selection and evaluation of treatment response.

Benefits

Reduce time on suboptimal treatment for multiple sclerosis patients

Accurate assessment of brain atrophy and lesion evolution in MS allows the early evaluation of treatment response. This could realize a reduction of time on expensive suboptimal treatment from 3.9 years now to 1.3 years.

The diagnosis of dementia and head trauma depends on ability to assess local brain damage. With icobrain the brain atrophy and local abnormalities can be quantified reliably in relevant regions.

Save radiological reading time

The ever-increasing number of medical images puts a lot of pressure on radiologists. With icobrain, the reading of brain scans can be significantly reduced thanks to the seamless integration of reporting parameters and annotated images in the radiological workflow.

Improve consistency of radiological reading

Starting from objective and standardized measurements to monitor neurological disorders strongly improves the inter and intra rater variability of the radiological reading.

Features

Objectively assess the lesion dissemination in space and time with icobrain ms

Detect and quantify new and enlarging FLAIR white matter hyperintensities.

Monitor the evolution of T1 white matter hypointensities.

Easily assess the total volumes of white matter abnormalities and their evolution.

Assess the lesion distribution graphs following the McDonald criteria.

Detect and measure contrast-enhancing lesions.

Measure precisely the brain atrophy with icobrain ms

Track the annualized brain volume change in order to assess disease progression.

Compare whole brain and gray matter volumes to an age- and gender-matched average brain volume of a healthy population.